South Africa’s health products regulator has approved the Johnson & Johnson coronavirus vaccine for general use, subject to certain conditions. The country is already using the vaccine for frontline healthcare workers, but this has been in the form of a clinical trial. Government hopes to secure more than 30 million doses for use in the second and third phases of the country’s vaccination programme. Mark Roughton reports.
IN: “The challenge of vaccinating…”
OUT: SOC
DUR: 0:32
http://www.fsnradionews.com/feeds/0402J&J-vaccine-registered-in-SA.mp3